The US launch for UR Code arrives on the heels of an exhaustive RFI and RFP process used to identify U.S.-based partners for marketing and selling the UR Code product in the United States.

"Interest generated by that process has led to open discussions with several major laboratories and manufacturers that have a high degree if interest obtaining exclusive market or national distribution rights to the UR Code product," said Kim Christensen, Chief Executive Office of Marker Test.

"We are very excited about the success we’ve already achieved with UR Code’s entry into the U.S. market."

In the form of a soft gel capsule, UR Code provides an accurate, secure and cost-effective answer to common drug testing challenges by inhibiting manipulations, eliminating false negative results, ensuring sample integrity and protecting the privacy of the test subject.

Last summer, Christensen published "Paradigm Shift: A Blueprint for Value Recognition and Process Improvement in the U.S. Drug Testing Market," a white paper describing the urgency for change in the drug testing industry.